The effect of injection of 1:100 000 adrenaline solution in the pterygopalatine fossa on intra-operative bleeding during endoscopic sinonasal surgical procedures in chronic sinusitis: a blinded clinical trial

J Laryngol Otol. 2024 Jun;138(6):638-641. doi: 10.1017/S0022215123002311. Epub 2024 Jan 17.

Abstract

Objective: Rhinosinusitis is one of the most common reasons for a visit to otolaryngology clinics. Some patients are candidates for sinus surgery. Infiltration of 1:100 000 adrenaline in the pterygopalatine fossa was studied, with the aim of evaluating the effect on bleeding in the surgical field.

Methods: This double-blind clinical trial was conducted in 2021-2022 on 40 candidates for endoscopic sinus surgery. For each patient, one side of the pterygopalatine fossa was randomly selected to be infiltrated with a vasoconstrictor. Surgical field bleeding on each side was evaluated.

Results: Blood loss was 35.8 ± 20.9 ml in the study group and 38.4 ± 23.7 ml for the control group, with no statistically significant difference between groups (p = 0.49). In addition, there was no difference between the two groups in terms of the surgical field based on Boezaart scores.

Conclusion: Although there are some recommendations on the usage of vasoconstrictors via the pterygopalatine foramen, debate remains.

Keywords: Paranasal sinuses; bleeding; endoscope; pterygopalatine fossa.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Blood Loss, Surgical* / prevention & control
  • Blood Loss, Surgical* / statistics & numerical data
  • Chronic Disease
  • Double-Blind Method
  • Endoscopy* / adverse effects
  • Endoscopy* / methods
  • Epinephrine* / administration & dosage
  • Epinephrine* / adverse effects
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pterygopalatine Fossa* / surgery
  • Rhinitis / surgery
  • Sinusitis* / surgery
  • Vasoconstrictor Agents* / administration & dosage